trending Market Intelligence /marketintelligence/en/news-insights/trending/eloum1r8nfdvkmy5g7ad6g2 content esgSubNav
In This List

Audentes Therapeutics names president/COO

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Audentes Therapeutics names president/COO

Audentes Therapeutics Inc. promoted Natalie Holles to president and COO.

Holles was senior vice president and COO.

In the new role, she will oversee the day-to-day operations of the company, including research, development, manufacturing, program management and corporate development.

Holles joined Audentes in 2015, bringing 15 years of corporate development, strategic planning and commercial experience gained in a range of therapeutic areas and with a focus on rare diseases, Audentes said in a statement.